News

Article

Pharmaceutical Technology

Pharmaceutical Technology-03-15-2016
Volume2016 eBook
Issue 1
Pages: s40-s45

Meeting USP Guidelines for Elemental Impurity Analysis with X-ray Fluorescence Spectrometry

Author(s):

The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.

In sufficiently high concentrations, elemental impurities, typically from catalyst residue, can pose safety risks.  The author discusses how x-ray spectrometry can be an effective way to measure these impurities and meet regulatory guidelines.

Read this article

from Pharmaceutical Technology’s 2016 Solid Dosage Drug Development and Manufacturing eBook.

View other articles in the

2016 Solid Dosage Drug Development and Manufacturing eBook.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos